Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

VRTX Vertex Pharmaceuticals

292.410
+7.670+2.69%
Close 09/28 16:00 ET
292.4100.0000.00%
Post Mkt Price 09/28 16:40 ET
High
293.835
Open
289.280
Turnover
483.91M
Low
286.020
Pre Close
284.740
Volume
1.66M
Market Cap
74.99B
P/E(TTM)
23.68
52wk High
305.950
Shares
256.46M
P/E(Static)
32.45
52wk Low
176.360
Float Cap
74.16B
Bid/Ask %
0.00%
Historical High
306.080
Shs Float
253.62M
Volume Ratio
1.18
Historical Low
7.250
Dividend TTM
--
Div Yield TTM
--
P/B
6.28
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.65%
Amplitude
2.75%
Avg Price
292.130
Lot Size
1
Float Cap
74.16B
Bid/Ask %
0.00%
Historical High
306.080
Shs Float
253.62M
Volume Ratio
1.18
Historical Low
7.250
Dividend TTM
--
P/B
6.28
Dividend LFY
--
Turnover Ratio
0.65%
Amplitude
2.75%
Avg Price
292.130
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.
CEO: Dr. Reshma Kewalramani
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...